|
G
|
Acrbp
|
acrosin binding protein
|
increases expression
|
ISO
|
erastin results in increased expression of ACRBP mRNA alternative form
|
CTD |
PMID:35234341 |
|
NCBI chr 4:157,851,149...157,864,211
Ensembl chr 4:157,841,841...157,864,213
|
|
G
|
Acsl4
|
acyl-CoA synthetase long-chain family member 4
|
increases expression multiple interactions
|
ISO
|
erastin results in increased expression of ACSL4 protein leonurine inhibits the reaction [erastin results in increased expression of ACSL4 protein]
|
CTD |
PMID:38670420 |
|
NCBI chr X:110,739,633...110,803,416
Ensembl chr X:105,942,799...106,006,427
|
|
G
|
Ahr
|
aryl hydrocarbon receptor
|
multiple interactions affects response to substance
|
ISO
|
AHR protein affects the reaction [[indol-3-yl pyruvic acid co-treated with erastin] results in increased expression of SLC7A11 protein]; AHR protein affects the reaction [erastin results in increased expression of SLC7A11 mRNA]; AHR protein affects the reaction [erastin results in increased expression of SLC7A11 protein] AHR protein affects the susceptibility to erastin
|
CTD |
PMID:38641223 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
|
|
G
|
Ar
|
androgen receptor
|
affects response to substance
|
ISO
|
AR protein affects the susceptibility to erastin
|
CTD |
PMID:39309439 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
|
|
G
|
Arid3a
|
AT-rich interaction domain 3A
|
multiple interactions increases expression
|
ISO
|
Doxycycline promotes the reaction [erastin results in increased expression of ARID3A mRNA]
|
CTD |
PMID:38115220 |
|
NCBI chr 7:9,755,291...9,781,260
Ensembl chr 7:9,755,294...9,780,599
|
|
G
|
Atf4
|
activating transcription factor 4
|
multiple interactions increases expression
|
ISO
|
leonurine inhibits the reaction [erastin results in increased expression of ATF4 protein]
|
CTD |
PMID:38670420 |
|
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:111,804,183...111,806,446
|
|
G
|
Atg5
|
autophagy related 5
|
increases expression
|
EXP
|
erastin results in increased expression of ATG5 protein
|
CTD |
PMID:32937103 |
|
NCBI chr20:49,380,835...49,471,826
Ensembl chr20:47,798,290...47,889,209
|
|
G
|
Bgn
|
biglycan
|
multiple interactions decreases expression
|
ISO
|
BGN mRNA alternative form inhibits the reaction [erastin results in decreased expression of MKI67 protein]; erastin inhibits the reaction [[Antineoplastic Agents, Immunological results in decreased susceptibility to Antineoplastic Agents, Immunological] which results in increased expression of BGN mRNA alternative form] erastin results in decreased expression of BGN mRNA alternative form
|
CTD |
PMID:35234341 |
|
NCBI chr X:156,348,633...156,360,797
Ensembl chr X:151,197,273...151,209,461
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions increases cleavage
|
ISO
|
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide promotes the reaction [erastin results in increased cleavage of CASP3 protein]
|
CTD |
PMID:38641223 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G
|
Cebpd
|
CCAAT/enhancer binding protein delta
|
increases expression multiple interactions
|
ISO
|
erastin results in increased expression of CEBPD mRNA Doxycycline promotes the reaction [erastin results in increased expression of CEBPD mRNA]
|
CTD |
PMID:38115220 |
|
NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829
|
|
G
|
Chac1
|
ChaC glutathione-specific gamma-glutamylcyclotransferase 1
|
multiple interactions increases expression
|
ISO
|
GW 506033X inhibits the reaction [erastin results in increased expression of CHAC1 mRNA] leonurine inhibits the reaction [erastin results in increased expression of CHAC1 protein]
|
CTD |
PMID:30817950 PMID:38670420 |
|
NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:106,342,302...106,345,526
|
|
G
|
Chst4
|
carbohydrate sulfotransferase 4
|
increases expression multiple interactions
|
ISO
|
erastin results in increased expression of CHST4 mRNA Doxycycline promotes the reaction [erastin results in increased expression of CHST4 mRNA]
|
CTD |
PMID:38115220 |
|
NCBI chr19:37,993,471...38,002,123
Ensembl chr19:37,991,417...38,003,608
|
|
G
|
Cited2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
multiple interactions
|
ISO
|
[Doxycycline co-treated with erastin] results in increased expression of CITED2 mRNA
|
CTD |
PMID:38115220 |
|
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
|
|
G
|
Col1a2
|
collagen type I alpha 2 chain
|
increases expression
|
ISO
|
erastin results in increased expression of COL1A2 mRNA alternative form
|
CTD |
PMID:35234341 |
|
NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:32,563,381...32,598,867
|
|
G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
multiple interactions
|
ISO
|
erastin affects the reaction [CYP2E1 protein affects the susceptibility to Ethanol]
|
CTD |
PMID:33017621 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
|
|
G
|
Ddit3
|
DNA-damage inducible transcript 3
|
multiple interactions increases expression
|
ISO
|
erastin promotes the reaction [Silicon Dioxide results in increased expression of DDIT3 protein]; GW 506033X inhibits the reaction [erastin results in increased expression of DDIT3 mRNA] leonurine inhibits the reaction [erastin results in increased expression of DDIT3 protein]
|
CTD |
PMID:30817950 PMID:37075931 PMID:38670420 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
|
|
G
|
Dtl
|
denticleless E3 ubiquitin protein ligase homolog
|
increases expression
|
ISO
|
erastin results in increased expression of DTL mRNA alternative form
|
CTD |
PMID:35234341 |
|
NCBI chr13:105,646,908...105,685,921
Ensembl chr13:103,117,186...103,154,890
|
|
G
|
Eif2ak3
|
eukaryotic translation initiation factor 2 alpha kinase 3
|
multiple interactions
|
ISO
|
erastin results in increased expression of and results in increased phosphorylation of EIF2AK3 protein; leonurine inhibits the reaction [erastin results in increased expression of EIF2AK3 protein]
|
CTD |
PMID:38670420 |
|
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:102,805,510...102,866,911
|
|
G
|
Eif2s1
|
eukaryotic translation initiation factor 2 subunit alpha
|
multiple interactions
|
ISO
|
erastin results in increased expression of and results in increased phosphorylation of EIF2S1 protein; leonurine inhibits the reaction [erastin results in increased expression of and results in increased phosphorylation of EIF2S1 protein]
|
CTD |
PMID:38670420 |
|
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:97,672,766...97,706,225
|
|
G
|
Ern1
|
endoplasmic reticulum to nucleus signaling 1
|
multiple interactions increases phosphorylation
|
ISO
|
GW 506033X inhibits the reaction [erastin results in increased phosphorylation of ERN1 protein]
|
CTD |
PMID:30817950 |
|
NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,330,654...91,421,029
|
|
G
|
Fancd2
|
FA complementation group D2
|
decreases expression
|
EXP
|
erastin results in decreased expression of FANCD2 protein
|
CTD |
PMID:32937103 |
|
NCBI chr 4:148,234,633...148,299,035
Ensembl chr 4:146,679,179...146,743,412
|
|
G
|
Fasn
|
fatty acid synthase
|
affects response to substance decreases expression
|
ISO
|
FASN protein affects the susceptibility to erastin erastin results in decreased expression of FASN protein
|
CTD |
PMID:39309439 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261
|
|
G
|
Fh
|
fumarate hydratase
|
decreases response to substance
|
ISO
|
FH protein results in decreased susceptibility to erastin
|
CTD |
PMID:29917289 |
|
NCBI chr13:90,056,565...90,082,450
Ensembl chr13:87,524,337...87,550,266
|
|
G
|
Fth1
|
ferritin heavy chain 1
|
multiple interactions increases expression
|
EXP ISO
|
3-methyladenine promotes the reaction [erastin results in increased expression of FTH1 protein]; Chloroquine promotes the reaction [erastin results in increased expression of FTH1 protein]; Deferiprone inhibits the reaction [erastin results in increased expression of FTH1 protein]; NFE2L2 protein promotes the reaction [erastin results in increased expression of FTH1 protein] [PRKD2 protein affects the susceptibility to erastin] which affects the expression of FTH1 protein; bafilomycin A1 affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of FTH1 protein]; Chloroquine affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of FTH1 protein]
|
CTD |
PMID:32937103 PMID:37951334 |
|
NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:206,627,103...206,725,424
|
|
G
|
Ftl1
|
ferritin light chain 1
|
multiple interactions
|
ISO
|
[PRKD2 protein affects the susceptibility to erastin] which affects the expression of FTL protein; bafilomycin A1 affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of FTL protein]; Chloroquine affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of FTL protein]
|
CTD |
PMID:37951334 |
|
NCBI chr 1:105,072,858...105,074,705
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
|
|
G
|
Gabarapl1
|
GABA type A receptor associated protein like 1
|
increases expression multiple interactions
|
ISO
|
erastin results in increased expression of GABARAPL1 mRNA Doxycycline promotes the reaction [erastin results in increased expression of GABARAPL1 mRNA]
|
CTD |
PMID:38115220 |
|
NCBI chr 4:164,666,332...164,675,474
Ensembl chr 4:162,980,249...162,989,450
|
|
G
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit
|
multiple interactions increases expression
|
EXP
|
NFE2L2 protein promotes the reaction [erastin results in increased expression of GCLC protein]
|
CTD |
PMID:32937103 |
|
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
|
|
G
|
Gclm
|
glutamate cysteine ligase, modifier subunit
|
increases expression multiple interactions
|
EXP
|
erastin results in increased expression of GCLM protein NFE2L2 protein promotes the reaction [erastin results in increased expression of GCLM protein]
|
CTD |
PMID:32937103 |
|
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
|
|
G
|
Gja1
|
gap junction protein, alpha 1
|
multiple interactions
|
ISO
|
GJA1 protein affects the reaction [erastin results in decreased expression of GPX4 protein]; GJA1 protein affects the reaction [erastin results in decreased expression of SLC7A11 protein]
|
CTD |
PMID:34785303 |
|
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:35,755,991...35,768,582
|
|
G
|
Gpx4
|
glutathione peroxidase 4
|
decreases expression multiple interactions
|
ISO EXP
|
erastin results in decreased expression of GPX4 protein astaxanthine inhibits the reaction [erastin results in decreased expression of GPX4 protein]; ferrostatin-1 inhibits the reaction [erastin results in decreased expression of GPX4 protein]; gap 27 peptide inhibits the reaction [erastin results in decreased expression of GPX4 protein]; GJA1 protein affects the reaction [erastin results in decreased expression of GPX4 protein]; SESN1 protein inhibits the reaction [erastin results in decreased expression of GPX4 protein] erastin promotes the reaction [Silicon Dioxide results in decreased expression of GPX4 protein]
|
CTD |
PMID:31323261 PMID:32937103 PMID:34785303 PMID:37075931 PMID:37648051 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
multiple interactions increases expression
|
ISO
|
cordycepin inhibits the reaction [erastin results in increased expression of GSK3B protein]
|
CTD |
PMID:38014886 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
|
|
G
|
Havcr1
|
hepatitis A virus cellular receptor 1
|
multiple interactions
|
ISO
|
erastin inhibits the reaction [Quercetin inhibits the reaction [ochratoxin A results in increased expression of HAVCR1 mRNA]]
|
CTD |
PMID:39053875 |
|
NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,119,088...31,151,698
|
|
G
|
Hmga2
|
high mobility group AT-hook 2
|
multiple interactions increases expression
|
ISO
|
Doxycycline promotes the reaction [erastin results in increased expression of HMGA2 mRNA]
|
CTD |
PMID:38115220 |
|
NCBI chr 7:57,762,710...57,884,555
Ensembl chr 7:55,880,112...55,994,784
|
|
G
|
Hmox1
|
heme oxygenase 1
|
increases expression multiple interactions increases response to substance
|
ISO
|
erastin results in increased expression of HMOX1 protein erastin results in increased expression of HMOX1 mRNA; erastin results in increased expression of HMOX1 protein Doxycycline promotes the reaction [erastin results in increased expression of HMOX1 mRNA] HMOX1 protein results in increased susceptibility to erastin
|
CTD |
PMID:30817950 PMID:38115220 PMID:38641223 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
|
|
G
|
Hras
|
HRas proto-oncogene, GTPase
|
increases response to substance
|
ISO
|
HRAS protein modified form results in increased susceptibility to erastin
|
CTD |
PMID:17568748 |
|
NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:196,296,263...196,300,615
|
|
G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
increases expression multiple interactions
|
ISO
|
erastin results in increased expression of HSPA5 protein erastin promotes the reaction [Silicon Dioxide results in increased expression of HSPA5 protein]
|
CTD |
PMID:37075931 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
|
|
G
|
Hspb1
|
heat shock protein family B (small) member 1
|
decreases phosphorylation
|
EXP
|
erastin results in decreased phosphorylation of HSPB1 protein
|
CTD |
PMID:32937103 |
|
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:20,794,028...20,795,743
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
ISO
|
erastin inhibits the reaction [Quercetin inhibits the reaction [ochratoxin A results in increased expression of IL1B mRNA]]
|
CTD |
PMID:39053875 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
|
|
G
|
Il6
|
interleukin 6
|
multiple interactions
|
ISO
|
erastin inhibits the reaction [Quercetin inhibits the reaction [ochratoxin A results in increased expression of IL6 mRNA]]
|
CTD |
PMID:39053875 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G
|
Krt5
|
keratin 5
|
multiple interactions increases expression
|
ISO
|
Doxycycline promotes the reaction [erastin results in increased expression of KRT5 mRNA]
|
CTD |
PMID:38115220 |
|
NCBI chr 7:132,846,132...132,851,861
Ensembl chr 7:132,846,136...132,851,850
|
|
G
|
Map1lc3b
|
microtubule-associated protein 1 light chain 3 beta
|
increases expression multiple interactions
|
EXP
|
erastin results in increased expression of MAP1LC3B protein modified form 3-methyladenine inhibits the reaction [erastin results in increased expression of MAP1LC3B protein modified form]; Chloroquine promotes the reaction [erastin results in increased expression of MAP1LC3B protein modified form]
|
CTD |
PMID:32937103 |
|
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
increases phosphorylation multiple interactions
|
ISO
|
erastin results in increased phosphorylation of MAPK1 protein GW 506033X inhibits the reaction [erastin results in increased phosphorylation of MAPK1 protein]
|
CTD |
PMID:30817950 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions increases phosphorylation
|
ISO
|
GW 506033X inhibits the reaction [erastin results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:30817950 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
|
|
G
|
Mapk8
|
mitogen-activated protein kinase 8
|
increases phosphorylation multiple interactions
|
ISO
|
erastin results in increased phosphorylation of MAPK8 protein GW 506033X inhibits the reaction [erastin results in increased phosphorylation of MAPK8 protein]
|
CTD |
PMID:30817950 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
|
|
G
|
Mb
|
myoglobin
|
multiple interactions increases expression increases response to substance
|
ISO
|
Doxycycline promotes the reaction [erastin results in increased expression of MB mRNA] MB protein results in increased susceptibility to erastin
|
CTD |
PMID:38115220 |
|
NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:108,759,904...108,767,383
|
|
G
|
Mki67
|
marker of proliferation Ki-67
|
decreases expression multiple interactions
|
ISO
|
erastin results in decreased expression of MKI67 protein BGN mRNA alternative form inhibits the reaction [erastin results in decreased expression of MKI67 protein] Butyric Acid promotes the reaction [erastin results in decreased expression of MKI67 protein]
|
CTD |
PMID:35234341 PMID:37341073 |
|
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762
|
|
G
|
Msh2
|
mutS homolog 2
|
increases expression
|
ISO
|
erastin results in increased expression of MSH2 mRNA alternative form
|
CTD |
PMID:35234341 |
|
NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:6,813,795...6,872,938
|
|
G
|
Ncoa4
|
nuclear receptor coactivator 4
|
decreases expression multiple interactions
|
EXP ISO
|
erastin results in decreased expression of NCOA4 protein 3-methyladenine inhibits the reaction [erastin results in decreased expression of NCOA4 protein]; Chloroquine inhibits the reaction [erastin results in decreased expression of NCOA4 protein] [PRKD2 protein affects the susceptibility to erastin] which affects the expression of NCOA4 protein; bafilomycin A1 affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of NCOA4 protein]; Chloroquine affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of NCOA4 protein]
|
CTD |
PMID:32937103 PMID:37951334 |
|
NCBI chr16:7,389,222...7,409,564
Ensembl chr16:7,366,542...7,409,641 Ensembl chr16:7,366,542...7,409,641
|
|
G
|
Nfatc2
|
nuclear factor of activated T-cells 2
|
multiple interactions
|
ISO
|
erastin promotes the reaction [Silicon Dioxide results in increased expression of NFATC2 protein]
|
CTD |
PMID:37075931 |
|
NCBI chr 3:177,615,189...177,747,493
Ensembl chr 3:157,198,872...157,328,325
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions increases expression decreases expression affects response to substance
|
ISO EXP
|
NFE2L2 protein affects the reaction [erastin results in increased expression of SESN2 protein] NFE2L2 protein promotes the reaction [erastin results in increased expression of FTH1 protein]; NFE2L2 protein promotes the reaction [erastin results in increased expression of GCLC protein]; NFE2L2 protein promotes the reaction [erastin results in increased expression of GCLM protein]; NFE2L2 protein promotes the reaction [erastin results in increased expression of SLC7A11 mRNA] erastin results in increased expression of NFE2L2 protein cordycepin inhibits the reaction [erastin results in decreased expression of NFE2L2 protein]; NFE2L2 protein affects the reaction [erastin results in increased expression of SESN2 protein] NFE2L2 protein affects the susceptibility to erastin
|
CTD |
PMID:31323261 PMID:32937103 PMID:38014886 PMID:38636790 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
|
|
G
|
Ntn1
|
netrin 1
|
multiple interactions
|
ISO
|
erastin inhibits the reaction [Quercetin inhibits the reaction [ochratoxin A results in increased expression of NTN1 mRNA]]
|
CTD |
PMID:39053875 |
|
NCBI chr10:52,899,933...53,098,591
Ensembl chr10:52,899,934...53,085,326
|
|
G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
increases cleavage multiple interactions
|
ISO
|
erastin results in increased cleavage of PARP1 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide promotes the reaction [erastin results in increased cleavage of PARP1 protein]
|
CTD |
PMID:38641223 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
|
|
G
|
Prkd2
|
protein kinase D2
|
affects response to substance multiple interactions
|
ISO
|
PRKD2 protein affects the susceptibility to erastin [PRKD2 protein affects the susceptibility to [erastin co-treated with bafilomycin A1]] which affects the abundance of Malondialdehyde; [PRKD2 protein affects the susceptibility to erastin] which affects the abundance of Malondialdehyde; [PRKD2 protein affects the susceptibility to erastin] which affects the expression of FTH1 protein; [PRKD2 protein affects the susceptibility to erastin] which affects the expression of FTL protein; [PRKD2 protein affects the susceptibility to erastin] which affects the expression of NCOA4 protein; bafilomycin A1 affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of FTH1 protein]; bafilomycin A1 affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of FTL protein]; bafilomycin A1 affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of NCOA4 protein]; Chloroquine affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of FTH1 protein]; Chloroquine affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of FTL protein]; Chloroquine affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of NCOA4 protein]; PRKD2 protein affects the susceptibility to [erastin co-treated with bafilomycin A1]
|
CTD |
PMID:37951334 |
|
NCBI chr 1:86,640,095...86,670,476
Ensembl chr 1:77,513,986...77,542,376
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
increases expression multiple interactions decreases expression
|
EXP ISO
|
erastin results in increased expression of PTGS2 mRNA; erastin results in increased expression of PTGS2 protein erastin analog results in increased expression of PTGS2 mRNA; erastin results in increased expression of PTGS2 mRNA Vitamin E inhibits the reaction [erastin analog results in increased expression of PTGS2 mRNA] erastin results in decreased expression of PTGS2 protein Quercetin inhibits the reaction [erastin results in increased expression of PTGS2 protein]; Quercetin promotes the reaction [erastin results in decreased expression of PTGS2 protein]
|
CTD |
PMID:24439385 PMID:32937103 PMID:37230155 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
|
|
G
|
Rnasel
|
ribonuclease L
|
increases expression multiple interactions
|
ISO
|
erastin results in increased expression of RNASEL mRNA Doxycycline promotes the reaction [erastin results in increased expression of RNASEL mRNA]
|
CTD |
PMID:38115220 |
|
NCBI chr13:68,446,641...68,460,804
Ensembl chr13:65,901,459...65,908,704
|
|
G
|
Rnf38
|
ring finger protein 38
|
multiple interactions
|
ISO
|
[Doxycycline co-treated with erastin] results in increased expression of RNF38 mRNA
|
CTD |
PMID:38115220 |
|
NCBI chr 5:63,154,507...63,263,138
Ensembl chr 5:58,361,976...58,467,446
|
|
G
|
Sc5d
|
sterol-C5-desaturase
|
increases expression
|
ISO
|
erastin results in increased expression of SC5D mRNA alternative form
|
CTD |
PMID:35234341 |
|
NCBI chr 8:42,629,649...42,641,257
Ensembl chr 8:42,632,672...42,641,273
|
|
G
|
Sesn1
|
sestrin 1
|
multiple interactions
|
ISO
|
SESN1 protein inhibits the reaction [erastin results in decreased expression of GPX4 protein]
|
CTD |
PMID:31323261 |
|
NCBI chr20:46,876,918...46,970,010
Ensembl chr20:45,294,871...45,387,697
|
|
G
|
Sesn2
|
sestrin 2
|
multiple interactions increases expression
|
ISO
|
NFE2L2 protein affects the reaction [erastin results in increased expression of SESN2 protein] erastin results in increased expression of SESN2 mRNA; erastin results in increased expression of SESN2 protein Acetylcysteine inhibits the reaction [erastin results in increased expression of SESN2 protein]; Butylated Hydroxyanisole inhibits the reaction [erastin results in increased expression of SESN2 protein]; Dactinomycin inhibits the reaction [erastin results in increased expression of SESN2 mRNA]; Deferoxamine inhibits the reaction [erastin results in increased expression of SESN2 protein]; diphenyleneiodonium inhibits the reaction [erastin results in increased expression of SESN2 protein]; ferrostatin-1 inhibits the reaction [erastin results in increased expression of SESN2 protein]; NFE2L2 protein affects the reaction [erastin results in increased expression of SESN2 protein]
|
CTD |
PMID:31323261 |
|
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
|
|
G
|
Slc11a2
|
solute carrier family 11 member 2
|
increases expression
|
EXP
|
erastin results in increased expression of SLC11A2 protein
|
CTD |
PMID:32937103 |
|
NCBI chr 7:133,381,878...133,429,921
Ensembl chr 7:131,503,081...131,540,145
|
|
G
|
Slc40a1
|
solute carrier family 40 member 1
|
decreases expression increases expression
|
EXP ISO
|
erastin results in decreased expression of SLC40A1 protein erastin results in increased expression of SLC40A1 protein
|
CTD |
PMID:31323261 PMID:32937103 |
|
NCBI chr 9:55,525,457...55,633,463
Ensembl chr 9:48,033,526...48,051,481
|
|
G
|
Slc7a11
|
solute carrier family 7 member 11
|
increases expression multiple interactions decreases expression
|
EXP ISO
|
erastin results in increased expression of SLC7A11 mRNA NFE2L2 protein promotes the reaction [erastin results in increased expression of SLC7A11 mRNA] 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[indol-3-yl pyruvic acid co-treated with erastin] results in increased expression of SLC7A11 protein]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [erastin results in increased expression of SLC7A11 protein]; [indol-3-yl pyruvic acid co-treated with erastin] results in increased expression of SLC7A11 protein; AHR protein affects the reaction [[indol-3-yl pyruvic acid co-treated with erastin] results in increased expression of SLC7A11 protein]; AHR protein affects the reaction [erastin results in increased expression of SLC7A11 mRNA]; AHR protein affects the reaction [erastin results in increased expression of SLC7A11 protein]; gap 27 peptide inhibits the reaction [erastin results in decreased expression of SLC7A11 protein]; GJA1 protein affects the reaction [erastin results in decreased expression of SLC7A11 protein] erastin promotes the reaction [Silicon Dioxide results in decreased expression of SLC7A11 protein] erastin results in increased expression of SLC7A11 mRNA; erastin results in increased expression of SLC7A11 protein
|
CTD |
PMID:32937103 PMID:34785303 PMID:37075931 PMID:38641223 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G
|
Slpi
|
secretory leukocyte peptidase inhibitor
|
multiple interactions increases expression
|
ISO
|
Doxycycline promotes the reaction [erastin results in increased expression of SLPI mRNA]
|
CTD |
PMID:38115220 |
|
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
|
|
G
|
Srebf1
|
sterol regulatory element binding transcription factor 1
|
decreases expression
|
ISO
|
erastin results in decreased expression of SREBF1 protein
|
CTD |
PMID:39309439 |
|
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,007,637...45,029,650
|
|
G
|
Taf1a
|
TATA-box binding protein associated factor, RNA polymerase I subunit A
|
decreases expression
|
ISO
|
erastin results in decreased expression of TAF1A mRNA alternative form
|
CTD |
PMID:35234341 |
|
NCBI chr13:95,012,160...95,048,131
Ensembl chr13:95,029,225...95,048,087
|
|
G
|
Tf
|
transferrin
|
increases expression multiple interactions
|
EXP
|
erastin results in increased expression of TF mRNA; erastin results in increased expression of TF protein Quercetin inhibits the reaction [erastin results in increased expression of TF mRNA]; Quercetin inhibits the reaction [erastin results in increased expression of TF protein]
|
CTD |
PMID:32937103 PMID:37230155 |
|
NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:103,767,995...103,816,511
|
|
G
|
Tfrc
|
transferrin receptor
|
increases expression
|
EXP ISO
|
erastin results in increased expression of TFRC protein
|
CTD |
PMID:31323261 PMID:32937103 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G
|
Timp1
|
TIMP metallopeptidase inhibitor 1
|
decreases expression
|
ISO
|
erastin results in decreased expression of TIMP1 mRNA alternative form
|
CTD |
PMID:35234341 |
|
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:1,212,972...1,217,664
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
ISO
|
erastin inhibits the reaction [Quercetin inhibits the reaction [ochratoxin A results in increased expression of TNF mRNA]]; erastin inhibits the reaction [Quercetin inhibits the reaction [ochratoxin A results in increased expression of TNF protein]]
|
CTD |
PMID:39053875 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G
|
Txnrd1
|
thioredoxin reductase 1
|
affects response to substance
|
ISO
|
TXNRD1 protein affects the susceptibility to erastin
|
CTD |
PMID:38636790 |
|
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:20,830,045...20,907,863
|
|
G
|
Vdac2
|
voltage-dependent anion channel 2
|
decreases expression increases degradation affects binding
|
ISO EXP
|
erastin results in decreased expression of VDAC2 protein erastin results in increased degradation of VDAC2 protein erastin analog binds to VDAC2 protein
|
CTD |
PMID:17568748 PMID:32937103 |
|
NCBI chr15:2,512,214...2,526,105
Ensembl chr15:2,463,056...2,476,553
|
|
G
|
Vdac3
|
voltage-dependent anion channel 3
|
increases degradation affects response to substance decreases expression
|
EXP ISO
|
erastin results in increased degradation of VDAC3 protein VDAC3 protein affects the susceptibility to erastin erastin results in decreased expression of VDAC3 protein
|
CTD |
PMID:17568748 PMID:32937103 |
|
NCBI chr16:76,137,489...76,153,933
Ensembl chr16:69,435,005...69,451,471
|
|
G
|
Wdr41
|
WD repeat domain 41
|
decreases expression
|
ISO
|
erastin results in decreased expression of WDR41 mRNA alternative form
|
CTD |
PMID:35234341 |
|
NCBI chr 2:26,222,797...26,273,849
Ensembl chr 2:26,224,495...26,273,836
|
|
G
|
Wnt5a
|
Wnt family member 5A
|
multiple interactions increases expression
|
ISO
|
erastin promotes the reaction [Silicon Dioxide results in increased expression of WNT5A protein] erastin results in increased expression of WNT5A protein
|
CTD |
PMID:37075931 |
|
NCBI chr16:3,702,300...3,724,860
Ensembl chr16:3,697,032...3,718,234
|
|